Professional Documents
Culture Documents
Istent Vs KDB
Istent Vs KDB
The Kahook Dual Blade® (KDB) goniotomy procedure yields significantly greater reductions in intraocular
pressure (IOP) and medication use compared to iStent ®, when combined with cataract surgery.*1
KDB iStent
Overall IOP Reduction 23.7% 16.4%
Overall Medication Reduction 62.9% 46.1%
-10.6 †
†
-15.0
-15
-13.9 -16.4
-12.7
-35
Day 1 Week 1 Month 1 Month 3 Month 6
Pre-op (1-3 days) (4-14 days) (15-59 days) (60-120 days) (121-270 days)
2
iStent
1.8
KDB
1.6
Mean # of Medications‡
1.4
% of patients with
1.2 ≥ 1 medication
1
reduction at 6 months
0.2
0
Pre-op Day 1 Week 1 Month 1 Month 3 Month 6
(1-3 days) (4-14 days) (15-59 days) (60-120 days) (121-270 days)
* Based on a retrospective analysis of KDB goniotomy (n = 237 eyes) vs. iStent (n = 198 eyes) in eyes with cataract and mild to moderate glaucoma undergoing cataract surgery, with
6 months of follow-up
† Indicates significant difference between both groups at an alpha of 0.05
‡ Mean values are rounded to one decimal place
Reference:
1. Mansouri K, et al. Comparison of the Intraocular Pressure Lowering Efficacy Between a Novel Goniotomy Blade and a Trabecular Meshwork Device. Presented at: The XXXV Congress of the
European Society of Cataract and Refractive Surgeons (ESCRS); October 7-11, 2017; Lisbon, Portugal.
Be Open to More Possibilities
The Kahook Dual Blade ® (KDB) allows you to treat a broad range of patients when the time
is right in their treatment progression. Its unique design allows you to perform a goniotomy:
• As a stand-alone procedure
• During cataract surgery
See how the Kahook Dual Blade lets you perform without limits.
www.KDBcert.com
© 2017 New World Medical, Inc. All rights reserved. New World Medical and Kahook Dual Blade are registered trademarks and Kahook is a trademark of
New World Medical, Inc. iStent is a registered trademark of Glaukos Corporation. 50-0116 Rev. New.